Why the study?
Despite a wide range of antihypertensive drugs, BP control often remains unsatisfactory, and the use of fixed-dose combinations is a key strategy to improve medical adherence.
Do fixed-dose combinations of antihypertensive drugs improve adherence and blood pressure control in patients with hypertension?
Do fixed-dose combinations of antihypertensive drugs improve adherence and blood pressure control in patients with hypertension?
The use of fixed-dose combinations of antihypertensive drugs is a key strategy to improve patient adherence and achieve better blood pressure control.
May support initial fixed-dose dual therapy to boost adherence in hypertension; leaves open optimal algorithms for randomized trials.
Despite a wide range of antihypertensive drugs, blood pressure (BP) control often remains unsatisfactory, and every year the number of people with uncontrolled high BP increases. One of the strategies aimed at improving medical adherence is the use of fixed-dose combinations of 2 antihypertensive drugs for starting therapy, and, if necessary, 3 drugs. Initiation of therapy with 2 drugs in one tablet is recommended for most patients. A review of algorithms for choosing combinations of antihypertensive drugs in different clinical situations, including in patients with various comorbid conditions, is presented. Simplification of treatment regimens makes it possible to choose the most optimal solutions in various clinical situations, in particular, with stage I-II hypertension, with a combination of hypertension with chronic kidney disease, as well as with a combination of hypertension with coronary artery disease and a number of other diseases.
No takes yet. Share an insight, caveat, or question.
Морозова et al. (2020) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: